Our Story
The Ono Pharma Foundation was established to support academic research in relevant scientific fields, which have the potential of making significant impact on therapeutic approaches to disease and pain management. The Foundation’s competitive awards program, the Ono Pharma Breakthrough Science Initiative Awards Program (“Ono Initiative”), is the embodiment of the Foundation’s commitment to focus on and accelerate researcher-driven open innovation by supporting high-risk and high-reward science research projects which have potential to lead to science discoveries/solutions and, possibly, based on further research, to breakthrough treatments for patients.
Our Mission
The purpose of the Ono Initiative is to support scientist Principal Investigators (“PIs”) with creative ideas in selected scientific research fields with the mission of seeking discoveries/solutions and development of high impact science.
The goals of the Ono Initiative are:
Supporting Innovation
Identify and help develop innovative research proposals and results that could lead to the development of breakthrough treatment solutions for patients.
Promoting Scientists
Support academic research and the career development of promising young and established scientists.
Building Relationships
Build strong relationships within the community in order to lead to transformative research aligned with the Ono Initiative’s goals.
Scientific Advisory Board
-
BENJAMIN F. CRAVATT, PH.D.
Chair of the Scientific Advisory Board
-
DAVID COREY, PH.D.
Vice Chairperson of the Scientific Advisory Board
-
CAROLYN R. BERTOZZI, PH.D.
Member of the Scientific Advisory Board
-
LAURA L. KIESSLING, PH.D.
Member of the Scientific Advisory Board
-
CHUAN HE, PH.D.
Member of the Scientific Advisory Board
FREQUENTLY ASKED QUESTIONS
The parties intend and agree that, to the extent allowable by U.S. intellectual property law, all intellectual property rights related to activities and research funded by the Grant shall be exclusively owned by the PI’s Institution. The Foundation disclaims any intellectual property and related rights developed by the research activities supported by the grant.